Our Abpromise guarantee covers the use of ab14922 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB 1/500. Predicted molecular weight: 37.7 kDa.


  • FunctionCondensing enzyme that elongates saturated and monounsaturated very long chain fatty acids (VLCFAs). Elongates C24:0 and C26:0 acyl-CoAs. Seems to represent a photoreceptor-specific component of the fatty acid elongation system residing on the endoplasmic reticulum. May be implicated in docosahexaenoic acid (DHA) biosynthesis, which requires dietary consumption of the essential alpha-linolenic acid and a subsequent series of three elongation steps.
  • Tissue specificityExpressed in the retina and at much lower level in the brain. Ubiquitous, highest expression in thymus, followed by testis, small intestine, ovary, and prostate. Little or no espression in heart, lung, liver, or leukocates.
  • Involvement in diseaseDefects in ELOVL4 are the cause of Stargardt disease type 3 (STGD3) [MIM:600110]. STGD is one of the most frequent causes of macular degeneration in childhood. It is characterized by macular dystrophy with juvenile-onset, rapidly progressive course, alterations of the peripheral retina, and subretinal deposition of lipofuscin-like material. STGD3 inheritance is autosomal dominant.
  • Sequence similaritiesBelongs to the ELO family.
  • DomainThe di-lysine motif may confer endoplasmic reticulum localization.
  • Cellular localizationEndoplasmic reticulum membrane.
  • Information by UniProt
  • Database links
  • Alternative names
    • 3-keto acyl-CoA synthase ELOVL4 antibody
    • ADMD antibody
    • Cancer/testis antigen 118 antibody
    • CT118 antibody
    • Elongation of very long chain fatty acids (FEN1/Elo2 SUR4/Elo3 yeast) like 4 antibody
    • Elongation of very long chain fatty acids like 4 antibody
    • Elongation of very long chain fatty acids protein 4 antibody
    • ELOV L4 antibody
    • ELOV4_HUMAN antibody
    • ELOVL 4 antibody
    • ELOVL4 antibody
    • FLJ17667 antibody
    • FLJ92876 antibody
    • Stargardt disease 3 antibody
    • Stargardt disease 3 autosomal dominant antibody
    • STGD 2 antibody
    • STGD 3 antibody
    • STGD2 antibody
    • STGD3 antibody
    see all

References for Anti-ELOVL4 antibody (ab14922)

This product has been referenced in:
  • Tikhonenko M  et al. Remodeling of retinal Fatty acids in an animal model of diabetes: a decrease in long-chain polyunsaturated fatty acids is associated with a decrease in fatty acid elongases Elovl2 and Elovl4. Diabetes 59:219-27 (2010). WB ; Rat . Read more (PubMed: 19875612) »
  • Condomines M  et al. Gene expression profiling and real-time PCR analyses identify novel potential cancer-testis antigens in multiple myeloma. J Immunol 183:832-40 (2009). WB ; Human . Read more (PubMed: 19542363) »

See all 3 Publications for this product

Product Wall

There are currently no Abreviews or Questions for ab14922.
Please use the links above to contact us or submit feedback about this product.